Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 03, 2023

BUY
$98.98 - $115.74 $39,097 - $45,717
395 Added 20.12%
2,358 $272,000
Q2 2023

Aug 07, 2023

SELL
$96.34 - $112.38 $20,231 - $23,599
-210 Reduced 9.66%
1,963 $201,000
Q1 2023

May 01, 2023

BUY
$107.32 - $113.5 $14,488 - $15,322
135 Added 6.62%
2,173 $237,000
Q4 2022

Feb 03, 2023

BUY
$62.39 - $113.8 $127,150 - $231,924
2,038 New
2,038 $231,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Ieq Capital, LLC Portfolio

Follow Ieq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.